Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply Variational AI’s Enki™ platform ...

Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...

Kubernetes has become the leading platform for deploying cloud-native applications and microservices, backed by an extensive community and comprehensive feature set for managing distributed systems.

Transforming drug discovery with generative AI Variational AI is using its Enki platform to explore uncharted regions of the chemical space, accelerating the discovery and development of ...

Nvidia Acquires Groq Talent In A Strategic To Move Into AI Inference in order to expand its AI ecosystem and take over the ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...

You train the model once, but you run it every day. Making sure your model has business context and guardrails to guarantee reliability is more valuable than fussing over LLMs. We’re years into the ...

The NR1® AI Inference Appliance, powered by the first true AI-CPU, now comes pre-optimized with Llama, Mistral, Qwen, Granite, and other generative and agentic AI models – making it 3x faster to ...

Amazon Web Services has initiated Global Cross-Region inference of Anthropic Claude Sonnet 4 in Amazon Bedrock, which makes it possible to direct the AI inference request to several AWS regions ...